Insider · CIK 0001681782
Brett R Hagen
Files at KLRS (Kalaris Therapeutics, Inc.). First filing Oct 23, 2024, latest Mar 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KLRS: Kalaris Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | KLRSsell Kalaris Therapeutics, Inc. | $8,135 907 shares | -32% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $967 96 shares | -3% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $342 36 shares | -1% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $146 332 shares | -0% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $304 554 shares | -1% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $1,431 1,655 shares | -2% | - | |
| 30Weak | Kalaris Therapeutics, Inc. | $746 965 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | KLRS Kalaris Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,262 | $0.00 | $0 | 50,262 | Apr 11, 2025 |
| Mar 26, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -907 | $8.97 | $8,135 | 1,925 | Mar 27, 2025 |
| Feb 21, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -96 | $10.08 | $967 | 2,832 | Feb 24, 2025 |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -32 | $9.45 | $303 | 2,932 | Jan 27, 2025 |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -4 | $9.94 | $40 | 2,928 | Jan 27, 2025 |
| Jan 10, 2025 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -332 | $0.44 | $146 | 68,174 | Jan 13, 2025 |
| Nov 19, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -554 | $0.55 | $304 | 68,506 | Nov 20, 2024 |
| Nov 5, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -1,655 | $0.86 | $1,431 | 69,060 | Nov 6, 2024 |
| Oct 21, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -479 | $0.78 | $373 | 71,201 | Oct 23, 2024 |
| Oct 22, 2024 | KLRS Kalaris Therapeutics, Inc. | SOpen-market sale Common Stock | -486 | $0.77 | $373 | 70,715 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.